CIK 0001819133 · Non-accelerated filer<br>Smaller reporting company
Tango Therapeutics, Inc.
Sign in to watch- Ticker
- TNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (857) 320-4900
- Business address
- 201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
- Former names
- BCTG Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,858,086
- in 6 filings, $1.9M under 10b5-1 plans
Net −$1,858,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-04 | Crystal Adam See Remarks | Sale | −7,432 | $2.99 | $22K | 165,061 |
| 2025-02-04 | Weber Barbara Chief Executive Officer | Sale | −9,778 | $2.99 | $29K | 1,631,264 |
| 2025-02-03 | Beckman Daniella Chief Financial Officer | Grant or award | +26,119 | 158,516 | ||
| 2025-02-03 | Beckman Daniella Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +156,713 | 156,713 | ||
| 2025-02-03 | Crystal Adam See Remarks | Grant or award | +53,015 | 172,493 | ||
| 2025-02-03 | Crystal Adam See Remarks | Grant or award · Stock Option (Right to Buy) | +318,090 | 318,090 | ||
| 2025-02-03 | Weber Barbara Chief Executive Officer | Grant or award | +105,875 | 1,641,042 | ||
| 2025-02-03 | Weber Barbara Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +635,250 | 635,250 | ||
| 2025-02-03 | Barry Douglas General Counsel | Grant or award | +27,363 | 71,344 | ||
| 2025-02-03 | Barry Douglas General Counsel | Grant or award · Stock Option (Right to Buy) | +164,175 | 164,175 | ||
| 2024-11-18 | Rothenberg Mace Director | Purchase | +10,000 | $3.78 | $38K | 31,250 |
| 2024-11-14 | Rothenberg Mace Director | Purchase | +10,000 | $3.62 | $36K | 21,250 |
| 2024-11-07 | EcoR1 Capital, LLC 10% owner | Sale | −62,318 | $3.29 | $205K | 11,773,860 |
| 2024-11-07 | EcoR1 Capital, LLC 10% owner | Sale | −1,143,124 | $2.92 | $3.3M | 10,630,736 |
| 2024-11-06 | EcoR1 Capital, LLC 10% owner | Sale | −1,494,558 | $3.28 | $4.9M | 11,836,178 |
| 2024-11-06 | Boxer Capital Management, LLC See remarks | Sale | −3,080,000 | $3.14 | $9.7M | 3,610,642 |
| 2024-10-25 | Boxer Capital Management, LLC See remarks. | Sale | −633,000 | $6.87 | $4.3M | 6,690,642 |
| 2024-10-22 | Boxer Capital Management, LLC See remarks | Sale | −250,000 | $6.78 | $1.7M | 7,323,642 |
| 2024-10-21 | Boxer Capital Management, LLC See remarks | Sale | −625,000 | $7.05 | $4.4M | 7,573,642 |
| 2024-09-13 | Third Rock Ventures IV, L.P. 10% owner | Sale | −67,400 | $10.53 | $710K | 16,859,075 |
Page 6 of 11 · 211 trades